Financials

  • Market Capitalization 69.55 M
  • Employee 20
  • Founded 2008
  • CEO N/A
  • Website www.ibioinc.com
  • Headquarter Delaware, United States
  • FIGI BBG000D5F2L9
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.44
Relación precio/flujo de caja
20.03

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4075
CSBR
Champions Oncology, Inc. - Common Stock
5.36 USD+1.71%-12.13%-10.22%-19.03%74.47 M USD
4095
GANX
Gain Therapeutics, Inc. - Common Stock
1.68 USD-4.55%-6.15%-15.58%+13.51%71.66 M USD
4116
SPRO
Spero Therapeutics, Inc. - Common Stock
1.17 USD-2.50%-4.10%-47.53%-45.58%67.74 M USD
4117
XBIT
XBiotech Inc. - Common Stock
2.23 USD-0.45%-1.76%-3.46%-25.17%67.99 M USD

Noticias